ISTA kept at sector perform by RBC

RBC Capital Markets analyst Douglas Miehm maintained ISTA Pharmaceuticals, Inc. at sector perform, speculative risk, after the company reported a second-quarter loss per share of $0.35, compared to a loss per share of $0.40 in the prior-year period. The analyst's estimate was a loss per share of $0.34. Total revenues of $7.5 million were in line with RBC's and the consensus estimate of $7.4 million. Shares of the Irvine, Calif.-based pharmaceutical company were down 4 cents, or 0.67%, at $5.94, on volume of 28,596 shares versus the three-month running average of 100,083 shares. (Nasdaq: ISTA)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.